{"id":211,"date":"2018-07-04T11:25:19","date_gmt":"2018-07-04T11:25:19","guid":{"rendered":"http:\/\/www.rbvrrwcp.org\/oldsite\/?page_id=211"},"modified":"2021-02-04T07:16:33","modified_gmt":"2021-02-04T07:16:33","slug":"projects","status":"publish","type":"page","link":"https:\/\/www.rbvrrwcp.org\/oldsite\/home\/projects\/","title":{"rendered":"Projects"},"content":{"rendered":"<h1 style=\"text-align: center;\"><strong>2017<\/strong><strong><br \/>\n<\/strong>Department of Pharma.Analysis<\/h1>\n<table style=\"text-align: left;\" width=\"799\">\n<tbody>\n<tr>\n<td width=\"66\"><strong>\u00a0<\/strong><strong>Sl.no<\/strong><\/td>\n<td style=\"text-align: left;\" width=\"491\"><strong>\u00a0<\/strong><strong>Title of the Project<br \/>\n<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"66\">1.<\/td>\n<td width=\"491\">Method development and validation of Moxifloxacin using RP-HPLC and UV-Method<br \/>\nA.Chaitanya Dr. M.Sumakanth M.Pharm Ph.D<\/td>\n<\/tr>\n<tr>\n<td width=\"66\">2.<\/td>\n<td width=\"491\">Method development and validation of ATOMOXETINE by RP-HPLC and UV-method.\u00a0 T.Priyanka, Dr. M.Sumakanth M.Pharm Ph.D<\/td>\n<\/tr>\n<tr>\n<td width=\"66\">3.<\/td>\n<td width=\"491\">A Simple rapid and sensitive method development for quantification of quetapine fumarate in bulk and dosage forms using RP-HPLC and UV Method .Teepoju Priyanka ,Dr. M.Sumakanth M.Pharm Ph.D<\/td>\n<\/tr>\n<tr>\n<td width=\"66\">4.<\/td>\n<td width=\"491\">\u00a0RP-HPLC and UV method development and validation for estimation of\u00a0 bosenton in bulk and pharmaceutical formulation K. Sai Kalyani Dr. M.Sumakanth M.Pharm Ph.D<\/td>\n<\/tr>\n<tr>\n<td width=\"66\">5.<\/td>\n<td width=\"491\">\u00a0Method development and validation\u00a0 of ziprasidone by using RP-HPLC\u00a0 and UV in bulk and dosage forms G.Sai Sindhu M.Sumakanth M.Pharm Ph.D<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>Department of <\/strong>Pharmaceutics<\/h1>\n<h1 style=\"text-align: center;\"><strong><u>2018<\/u><\/strong><strong><u><br \/>\n<\/u><\/strong><\/h1>\n<p><strong>\u00a0<\/strong><\/p>\n<table style=\"height: 1188px;\" width=\"902\">\n<tbody>\n<tr>\n<td width=\"49\"><strong>S.No.<\/strong><\/td>\n<td width=\"558\"><strong>Title of the Thesis<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"49\">1<\/td>\n<td width=\"558\">Preparation and Characterization of Letrozole loaded Ethyl Cellulose &amp; Eudragit S100 Nanoparticles by Solvent Evaporation &amp; Nanoprecipitation Techniques, Aisha Tabassum<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">2<\/td>\n<td width=\"558\">Formulation and evaluation of Ropinirole Hydrochloride Buccal Tablets ,Kommu Anusha<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">3<\/td>\n<td width=\"558\">Preparation and Characterization of Methotrexate Loaded polymeric nanoparticles by nanoprecipitation Technique and Solid lipid nanoparticles by micro emulsion technique<\/p>\n<p>Ayesha Siddiqua Gazi<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">4<\/td>\n<td width=\"558\">Preparation and Characterization of Nanoparticulate Drug delivery system for Naproxen Sodium using various Desolvating Agents, Huda Syed<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">5<\/td>\n<td width=\"558\">Formulation and Evaluation of ORO-Dispersable tablets of Drotavarine HCL, Padullaparti Lakshmi Krithika<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">6<\/td>\n<td width=\"558\">Development and Characterization of Fast Dissolving film of Domperidone, Pushpala Mounika<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">7<\/td>\n<td width=\"558\">Development of Nanoparticle drug delivery system for Cassia Senna extract, Danapagari Pravallika<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">8<\/td>\n<td width=\"558\">Formulation and Evaluation of Simvastatin loaded polymeric nanoparticles by emulsification solvent evaporation method, Etikala Priyanka<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">9<\/td>\n<td width=\"558\">Formulation and Evaluation of alcohol resistant tablet dosage forms of Quetiapine Fumarate, Salla Ramyasri<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">10<\/td>\n<td width=\"558\">Formulation and evaluation of solid dispersions and nano emulsions of febuxostat, M. Sanjana Reddy<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">11<\/td>\n<td width=\"558\">Formulation and evaluation of curcumin loaded nanoparticles, M\u00a0 Shruti<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">12<\/td>\n<td width=\"558\">Formulation and evaluation of solid lipid nanoparticles of etoricoxib by employing glyceryl monostearate, Balka Swetharani<\/td>\n<\/tr>\n<tr>\n<td width=\"49\">13<\/td>\n<td width=\"558\">Formulation and Evaluation of Gastroretentive \u2013 Mucoadhesive Tablets of Carvedilol, G Santoshini Reddy<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p style=\"text-align: center;\"><strong><u>\u00a0<\/u><\/strong><\/p>\n<h1 style=\"text-align: center;\"><strong><u>2017<\/u><\/strong><\/h1>\n<table style=\"height: 962px;\" width=\"897\">\n<tbody>\n<tr>\n<td width=\"57\"><strong>S.No.<\/strong><\/td>\n<td width=\"586\"><strong>Title of the Thesis <\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>1<\/strong><\/td>\n<td width=\"586\"><strong>Formulation and Evaluation of Naproxen Sodium Transdermal Patch Using Natural Polymers. Afrah Siddique<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>2<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Solid Lipid Nanoparticles\u00a0 of Quetiapine Fumarate. Hari Anushree<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>3<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Oseltamivir Phosphate Immediate Release Tablets By Using Compression Coating\u00a0 Technique. Arshiya Farheen<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>4<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Gastroretentive Bosentan Monohydrate Tablets Using RaftTechnology. Mamatha Jirra<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>\u00a05<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Self Micro Emusifying Drug Delivery Systems Containing Exetimibe-BCS class II Drug. Pathuri Mounika<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>6<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Etoricoxib Transdermal Gel Based on Vesicular Drug Delivery Approaches. V.Ravalika<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>7<\/strong><\/td>\n<td width=\"586\"><strong>Preparation And Characterization of Naproxen Loaded Niosomes by Thin Film Hydration Technique And Ether Injection Method. M.Shreya<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>8<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Smedds fo Febuxostat A-BCS Class II Drug. G.Swetha<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>9<\/strong><\/td>\n<td width=\"586\"><strong>Preparation And Characterization of\u00a0 Naproxen Loaded Bovine Serum Albumin Nanoparticles By Desolvation\u00a0 Techniques And Emulsion Interfacial Reaction Method. Juveria Banu<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>10<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Solid Lipid Nonoparticles of\u00a0 Duloxetine . Nayela Aafreen<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"57\"><strong>11<\/strong><\/td>\n<td width=\"586\"><strong>Formulation And Evaluation of Metformin Hydrochloride Immediate Release Tablets By Using Low Density Excipents. Shaziya Tasneem<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><u><\/u><strong><u>2016<\/u><\/strong><\/h1>\n<p>&nbsp;<\/p>\n<table style=\"height: 553px;\" width=\"897\">\n<tbody>\n<tr>\n<td width=\"67\"><strong>S.No.<\/strong><\/td>\n<td width=\"558\"><strong>Title of the Thesis <\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"67\"><strong>1<\/strong><\/td>\n<td width=\"558\"><strong>Formulation and Evaluation of Mouth Dissolving Ablets of Statins by Tase MaskingAgent Employing Solid Dispersion Technique. G.Nikitha<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"67\"><strong>2<\/strong><\/td>\n<td width=\"558\"><strong>Formulation And Evaluation of Mefenamic Acid Transdermal Gel\u00a0 Based Vesicular Drug Delivery Approaches . B.Supraja<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"67\"><strong>3<\/strong><\/td>\n<td width=\"558\"><strong>Solibility Enhancement Studies on the Poorly soluble Drug febuxostat. Soumya Reddy<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"67\"><strong>4<\/strong><\/td>\n<td width=\"558\"><strong>Studies On Drug Release Patterns of API (Bosentan Monohyderate) by Solid Dipersion Technique . Kunche Lalitha Priyanka<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"67\"><strong>\u00a05<\/strong><\/td>\n<td width=\"558\"><strong>Development of ODT of Atorvastatin calcium Cyclodextrin complex using Natural Disintegrating Agents. Y.Sowmya<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"67\"><strong>6<\/strong><\/td>\n<td width=\"558\"><strong>Preparation and Evaluation of Naproxen Nanoparticles by Emulsion Intergacial Reaction Method And Desolvation Techniques. Ayesha Siddiqua<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2015<br \/>\n<\/strong><\/h1>\n<table class=\" alignleft\" style=\"height: 2384px;\" width=\"826\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td><strong>Title of the project<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td>Formulation and evaluation of ibuprofen loaded niosomal gel by thin film hydration and ether injection method,A.Krishna sailaja<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Formulation and evaluation of COX-2 inhibitor(Etoricoxib) loaded polymeric nanoparticles for topical drug delivery,A.Krishna sailaja<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Preparation and evaluation of naproxen sodium loaded liposomes,ethosomes and transferosomes,A.Krishna sailaja<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Formualtion and evalution of linagliptin and metformin hydrochloride immediate release tablets,<br \/>\nGopi Krishna (Scientist-Formulation Research and Development)G.Umarani,MSN Labs Private Limited, Pashamylaram, Medak<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Comparative study of sulphasalazine loaded microcapsules,microspheres &amp; microbeads,A.Krishna sailaja<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Preparation and evalution of mefenamic acid loaded microspheres using natural and synthetic polymers,A.Krishna sailaja<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Formulation and invitro evaluation of bupropion Hcl extended release matrix tablets,K.Subba Rao(Senior Executive-Formulation Research and Department) Internal guide: K.V. Ratnamala<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Study and Development of ODT tablet of candasartan celaxitil using banana powder as disintegrant,G.Umarani<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Process Optimization parameters of Ranolazine extended release tablets,G.RameshPDL Manager, Internal Guide: K.V. Ratnamala,Aurobindo Pharma Ltd<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Gastroretentive drug delivery system of ciprofloxacin hcl,Chetan tilwankerProductin manager<br \/>\nInternal guide:k.v .Ratnamala,Dr .reddy labsBachupally<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td>Formulation and evaluation of osmotic controlled drug delivery of nebivolol,K.Subba Rao(Senior Executive-Formulation Research and Department) Internal guide:A.Krishna Sailaj,Lara Drugs Private Limited, Nalgonda.<\/td>\n<\/tr>\n<tr>\n<td>12<\/td>\n<td>Formulation and invitro evaluation of gastroretentive drug delivery of perindopril erbumine by using Raft Approach,K.Subba Rao(Senior Executive-Formulation Research and Department)Internal guide:K.V. Ratnamala<\/td>\n<td><\/td>\n<td>L<\/td>\n<\/tr>\n<tr>\n<td>13<\/td>\n<td>Preparation and evaluation studies of Omeprazole microspheres<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>14<\/td>\n<td>Formulation &amp; invitro evaluation of liquisolid compact of felodipine,K.Subba Rao(Senior Executive-Formulation Research and Department)Internal guide:G.Umarani,Lara Drugs Private Limited,Nalgonda.<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td>Preparation and evaluation of naproxen sodium loaded Bovine serum albumin nanoparticles by desolvation method,A.Krishna sailaja,RBVRR Women\u2019s College of Pharmacy<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr \/>\n<h1 style=\"text-align: center;\"><strong>2015<\/strong><br \/>\n<strong>Department of\u00a0<\/strong> Pharmaceutical Chemistry<\/h1>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td><strong>Title of the project<\/strong><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td>Isolation ,characterization of phyto chemical constituents and pharmacological investigation of cissus vitiginea leaves.<\/p>\n<p>Dr.Sudha Parimala<\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr \/>\n<h1 style=\"text-align: center;\"><strong>2014<\/strong><br \/>\n<strong>Department of\u00a0<\/strong> Pharmaceutical Chemistry<\/h1>\n<table class=\" alignleft\" width=\"97%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"92%\"><strong>Tittle of the project<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"92%\">Insilico Screening of Novel substituted purine derivatives as HSP 90 Inhibitors by 3D QSAR and Docking studies .<\/p>\n<p><strong>V Priyanka Reddy, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor<\/strong><\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"92%\">Homology modeling of STAT 3 protien and virtual Screening of novel STAT 3 inhibitors by 3D QSAR and docking studies.<\/p>\n<p><strong>B Preethi, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor<\/strong><\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"92%\">Developing of new derivatives of Indenoisoquinolene as DNA topoisomerese inhibitor by using fragment based drug designing approach.<\/p>\n<p><strong>S Madhavi Latha, Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof.,\u00a0 M Sumakanth , M.Pharm,Ph.D (Internal)<\/strong><\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"92%\">Pharmacophore Modeling, 3D QSAR, ADMET and Docking studies of Benzisothiazol &amp; Oxadiazole hybrid derivatives as Dengue Virus NS2B\/NS3 Protease inhibitors.<\/p>\n<p><strong>Amreen Begum, Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth , M.Pharm,Ph.D<\/strong><strong>(Internal)<\/strong><\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"92%\">Virtual screening of new triazolo derivatives as JAK 2 inhibitors by 3D QSAR and docking studies.<\/p>\n<p><strong>M Mounika, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor<\/strong><\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"92%\">Homology modeling of TRPV1 protein and Insilico Screening of Novel Inhibitors by 3D QSAR and docking studies.<\/p>\n<p><strong>Ch.Srividya, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor<\/strong><\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"92%\">Insilico Screening of pyridoimidazolones &amp; substituted pyrazoles as novel inhibitors of B RAF kinase by 3D QSAR, and docking studies<strong>. <\/strong><\/p>\n<p><strong>S Haritha, Prof. M Sumakanth , M.Pharm,Ph.D Supervisor<\/strong><\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"92%\">Virtual screening of novel Rho kinase inhibitors by 3D QSAR and docking studies.<\/p>\n<p>N <strong>Vamshi Priya, Prof. M Sumakanth , M.Pharm,Ph.D(External)<\/strong><\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td width=\"92%\">Insilico Screening of novel 5 LOX inhibitors by 3D QSAR and docking studies.<\/p>\n<p><strong>Maderi Ayesha, Prof. M Sumakanth, M.Pharm,Ph.DSupervisor<\/strong><\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td width=\"92%\">Molecular modelling of Indoline derivatives as transforming growth factor beta receptor 1 (TGFBR) inhibitors by 3D QSAR and docking studies.<\/p>\n<p><strong>A Mounika, Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth, M.Pharm,Ph.D<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1><\/h1>\n<h1><\/h1>\n<h1><\/h1>\n<h1><\/h1>\n<h1 style=\"text-align: center;\"><strong>Department of\u00a0 <\/strong>Pharmaceutics<\/h1>\n<h1 style=\"text-align: center;\">2014<\/h1>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"93%\"><strong>Tittle of the project<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"93%\">Preparation and physicochemical characterization of vincristine sulphate loaded polycaprolactone nanoparticles by various techniques<strong>.<\/strong><\/p>\n<p><strong> A Tejasri, Dr. S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.<\/strong><strong>Mrs. G Uma Rani,M.Pharm (Internal)<\/strong><\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"93%\">Formulation and evaluation of extended release tablets of desvenlafaxine succinate.<\/p>\n<p><strong>Mucchrla Radhika, Mr.G Ramesh,PDL &amp; TTD Manager(External)Aurobindo Pharma Ltd. Dr. B L R Madhavi, M.Pharm,Ph.D (Internal)<\/strong><\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"93%\">Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by solvent evaporation technique and salting out method.<\/p>\n<p><strong>Aenugula Saritha Reddy, Dr. A Krishna Sailaja<\/strong><\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"93%\">Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by nanoprecipitation and ionic gelation method,<\/p>\n<p><strong>Pamulaparti Swathi, Dr. A Krishna Sailaja<\/strong><\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"93%\">Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by solvent evaporation and ionotropic gelation method.<\/p>\n<p><strong>Sreelola V, Dr. A Krishna Sailaja<\/strong><\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"93%\">Development &amp; characterization of xanthum gum and chitosan polyelectrolyte complex as drug delivery carrier.<\/p>\n<p><strong>Mamidi Vatsalya, Dr.S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.<\/strong><strong>Mrs. K V Ratnamala, M.Pharm<\/strong><\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"93%\">Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by nano precipitation and desolvation technique.<\/p>\n<p><strong>Chandavath Vineela, Dr.A Krishna Sailaja,<\/strong><\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"93%\">Formulation &amp; evaluation of or dispersible tablets of candasartan using natural super disintegrants.<\/p>\n<p><strong>Shaik Yasmeen, Mrs. G Uma Rani<\/strong><\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td width=\"93%\">Formulation and evalution oof immediate release tablets of quinaprial Hcl by direct compression method. <strong>Shwetha Margaret J L, Dr.B L R Madhavi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td width=\"93%\">Pallavi M, Mr.Sridhar,M.Pharm(External)Pelcoat formulations pvt.ltd, \u00a0Dr. A Krishna Sailaja<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td width=\"93%\">Formulation and evaluation of non effervescent gastric floating tablets of ceferoxime axitel.<\/p>\n<p><strong>Y Anisha,\u00a0 Mrs. K V Ratnamala<\/strong>,<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2013<br \/>\nDepartment of\u00a0 Pharmaceutical Chemistry<\/strong><\/h1>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"93%\"><strong>Tittle of Project<br \/>\n<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"93%\">Synthesis , Charecterization , Docking studies and Biological evalution of 2,4,5,6 tetra substituted Pyridazin-3(2H)-ones<strong>,\u00a0 <\/strong><\/p>\n<p><strong>Geetha Reddy K, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"93%\">Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Sulfamoyl Phenyl Pyridazinones,<\/p>\n<p><strong>Srujana S, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"93%\">Optimization , Charaterization &amp; impurity profile of Telmisartian by improved synthetic rout and evaluation of Antihypertensive activity of impurity (Chloro analaog),<\/p>\n<p><strong>K P Sunitha, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"93%\">Synthesis , Characterization and Docking studies of Novel series of Pyridazinone substituted Benzene Sulfonyl Ureas,<\/p>\n<p><strong>D Sai Sudha, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"93%\">Synthesis , Characterization , Docking and Biological Evalution of Novel Pyrimido(4,5-C) Pyridazines,<\/p>\n<p><strong>N Swetha, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"93%\">Synthesis , Characterization , and In-Sillico evalution of Phthalazine derivatives as Antihypertensive agents,<\/p>\n<p><strong>Sumala Ravuri, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"93%\">Synthesis , Characterization , Docking studies , and Biological evalution of Novel series of 4 Pyrazolyl Substituted Pyridazinones,<\/p>\n<p><strong>P Spandana, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"93%\">Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Mannich bases of pyridazin 3(2H) thione,<\/p>\n<p><strong>Tejaswini V, Prof.M.Sumakanth<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2013<br \/>\nDepartment of Pharmaceutics<\/strong><\/h1>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"93%\"><strong>Tittle of Project<br \/>\n<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"93%\">Design , Development and Evaluation of Prednisolone Sodium Phosphate Orodispersible Tablets.<\/p>\n<p><strong>C Bhavani Devi Dr.B.L.R. Madhavi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"93%\">Formulation and Evaluation of Sustained Release Matrix Tablets of Niacin<\/p>\n<p><strong>Sudi konda Naga Sravya Mrs. Ratnamala K V<\/strong><\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"93%\">Formulation , Characterization of imquimod w\/o\/w multiple emulsion for Novel Adjuvant delivery system <strong>Thumma Anusha Dr. H Sampath Kumar<\/strong><\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"93%\">Development and Evaluation of Compression coated timed release tablets of Candesartan Cilexetil for Chronotherapy<\/p>\n<p><strong>K Deepika Dr.B.L.R. Madhavi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"93%\">Formulation and Evaluation of Compression coated immediate release tablets of Oseltamivir Phosphate <strong>Bala Bharathi Ponnana Dr.B.L.R. Madhavi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"93%\">Formulation and Evaluation of Quinapril Hydrochloride for oral sustained release<\/p>\n<p><strong>Dara<\/strong> <strong>Swathisri Dr.B.L.R. Madhavi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"93%\">Development of Nasal drug delivery system of Atorvastatin Calcium for enhancing bioavailability <strong>Gariganti Swathi Mrs. G Uma Rani<\/strong><\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"93%\">Formulation and Evaluation of core coated colon specific tablets of Piroxicam<\/p>\n<p><strong>B Tejaswi Dr. A.K.Sailaja<\/strong><\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td width=\"93%\">A study of formulation of micro particle of Cefuroxime Axetil using Ethyl Cellulose<\/p>\n<p><strong>Domala Usha Dr.B.L.R. Madhavi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td width=\"93%\">Development and Evaluation of Naringenin loaded PLGA Nano particles for enhancement of oral Bioavailability<\/p>\n<p><strong>Anusha Gunukula Mr. S. Ramakrishna<\/strong><\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td width=\"93%\">Formulation and Evaluation of micro emulsions encompasing Muramyl dipeptide adjuvant as Novel Vaccine delivery system <strong>V Poornima Dr. H.M. Sampath Kumar<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2012<\/strong><strong><br \/>\n<\/strong> Department of Pharma Chemistry<\/h1>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"93%\"><strong>Tittle of Project<br \/>\n<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"93%\">Synthesis &amp; Docking studies of novel series of Pyridazine(6,1-c)(1,2,4) triazine derivatives as PDE4 inhibitors, <strong>Ms. S P Anupama, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"93%\">Development of Industrial process for N-methyl pyridine-2-aldoxamine salts of Pharmaceutical importance. <strong>Ms. Lateef Unnisa, Prof.M.Sumakanth&amp;Dr.M.N.A.Rao<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"93%\">A novel synthesis , Characterization and Docking studies of 2-Thio-Substituted Benzo(d)thiazole derivatives <strong>Ms. Paidakula Megha, Prof.M.Sumakanth&amp;Dr.Y.V.D.Nageswar<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"93%\">Synthesis characterization and docking studies of 2-substitutd 6-aryl pyridizin -3(2H)-ones as Dopaminengic agents <strong>Ms. N Mounika Jagan, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"93%\">Synthesis characterization and docking studies of some novel series of 7-(o-Triazolopyridazin-3yl)-4-methyl coumarins as cox-2 inhibitors, <strong>Ms. K Rama, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"93%\">Synthesis ,characterization ,&amp; docking studies of novel series of 2-[5(1H)tetrazolo]-yl-6-aryl-4,5-dihydro\/dehydro-pyridazin-3(2H)-on,e <strong>Ms. Saritha Pola, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"93%\">Synthesis and docking studies of 3,7-disubstituted Pyridazin[6,1-C][1,2,4)-Triazines as novel PDE-4 inhibitors, <strong>Ms. Spoorthi Pohar, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"93%\">Synthesis and molecular modeling of novel 2\u2013substituted -6-Aryl pyridazin-3(2H)ones as 5HT2A Antagonist,s <strong>Ms. A Sravya, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td width=\"93%\">Synthesis , characterization and biological evaluation of Mannich bases of 7(hydroxyl)-4-methyl coumarin derivatives, <strong>Ms. Sukanya Mandala, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td width=\"93%\">Synthesis , Characterization and biological evaluation of novel 1,2,3 Tri-substituted Indoles, \u00a0<strong>Ms. K Suneetha, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td width=\"93%\">Synthesis , characterization and biological evaluation of a Schiff\u2019s bases of 2-(2-oxo-2-aryl)ethyl Pyridazin-3-thiones. <strong>Ms. Nageswari P.V, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>12<\/td>\n<td width=\"93%\">Synthesis , Docking studies and in vitro evaluation of Novel 4-(benzo[d] thiazol-2-yl)-N-phenylalanine derivatives, <strong>Ms. N.S.P.Sirisha, Prof.M.Sumakanth&amp;Dr.Y.V.D.Nageswar<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>13<\/td>\n<td width=\"93%\">Synthesis , characterization and Docking studies of Novel 6-Aryl \u2013 2-(Piperidin-1-yl\/Pyrrolidin-1-yl) Benzothiazole derivatives. <strong>Ms. Vijaya Laxmi T, Prof.M.Sumakanth&amp;Dr.Rajeev.S.Menon<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>14<\/td>\n<td width=\"93%\">Molecular docking &amp; Virtual screening for Novel protein tyrosine Phosphatane 1B(PTPIB) inhebitors <strong>Ms. Rajitha Kalashikam, Dr.Pasupuleti Sreenivasa Rao<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td width=\"93%\">Homology Modeling &amp; validation of Human FGFR 4 tyrosine kinase domine using structure based studies <strong>Ms. Poonam Chakravarthy, Prof.M.Sumakanth<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>16<\/td>\n<td width=\"93%\">In-Silico of Inhibitors for the Human SIAH2, implications for Hypoxia- induced cancers. <strong>Sailaja Kota, Dr.Pasupuleti Sreenivasa Rao<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2014<br \/>\nDepartment of\u00a0 Pharmaceutical Chemistry<\/strong><\/h1>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td><\/td>\n<td><\/td>\n<td><strong>Title of the project<\/strong><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td><\/td>\n<td><\/td>\n<td>Insilico Screening of Novel substituted purine derivatives as HSP 90 Inhibitors by 3D QSAR and Docking studies .Prof. M Sumakanth , M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td><\/td>\n<td><\/td>\n<td>Homology modeling of STAT 3 protien and virtual Screening of novel STAT 3 inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td><\/td>\n<td><\/td>\n<td>Developing of new derivatives of Indenoisoquinolene as DNA topoisomerese inhibitor by using fragment based drug designing approach.Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth , M.Pharm,Ph.D(Internal)<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td><\/td>\n<td><\/td>\n<td>Pharmacophore Modeling, 3D QSAR, ADMET and Docking studies of Benzisothiazol &amp; Oxadiazole hybrid derivatives as Dengue Virus NS2B\/NS3 Protease inhibitors.Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth , M.Pharm,Ph.D(Internal)<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td><\/td>\n<td><\/td>\n<td>Virtual screening of new triazolo derivatives as JAK 2 inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td><\/td>\n<td><\/td>\n<td>Homology modeling of TRPV1 protein and Insilico Screening of Novel Inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td><\/td>\n<td><\/td>\n<td>Insilico Screening of pyridoimidazolones &amp; substituted pyrazoles as novel inhibitors of B RAF kinase by 3D QSAR, and docking studies.Prof. M Sumakanth , M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td><\/td>\n<td><\/td>\n<td>Virtual screening of novel Rho kinase inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth , M.Pharm,Ph.D(External)<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td><\/td>\n<td><\/td>\n<td>Insilico Screening of novel 5 LOX inhibitors by 3D QSAR and docking studies.Prof. M Sumakanth, M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td><\/td>\n<td><\/td>\n<td>Molecular modelling of Indoline derivatives as transforming growth factor beta receptor 1 (TGFBR) inhibitors by 3D QSAR and docking studies.Dr. Manoj Kumar Mahto, Ph.D(External)Aravinda Biosolutions Pvt., Ltd.Prof. M Sumakanth, M.Pharm,Ph.D(Internal)<\/p>\n<p>&nbsp;<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr \/>\n<h1 style=\"text-align: center;\"><strong>2014<br \/>\nDepartment of Pharmaceutics<\/strong><\/h1>\n<table class=\" alignleft\" width=\"101%\">\n<tbody>\n<tr>\n<td><strong>.No.<\/strong><\/td>\n<td width=\"90%\"><strong>Tittle of the project<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"90%\">Preparation and physicochemical characterization of vincristine sulphate loaded polycaprolactone nanoparticles by various techniques.Dr. S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.Mrs. G Uma Rani,M.Pharm(Internal)<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"90%\">Formulation and evaluation of extended release tablets of desvenlafaxine succinate.Mr.G Ramesh,PDL &amp; TTD Manager(External)Aurobindo Pharma Ltd.Dr. B L R Madhavi, M.Pharm,Ph.D(Internal)<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"90%\">Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by solvent evaporation technique and salting out method.Dr. A Krishna Sailaja, M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"90%\">Preparation and characterization of sulphasalazine loaded polymeric nanoparticles by nanoprecipitation and ionic gelation methodDr. A Krishna Sailaja, M.Pharm, Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"90%\">Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by solvent evaporation and ionotropic gelation method.Dr. A Krishna Sailaja, M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"90%\">Development &amp; characterization of xanthum gum and chitosan polyelectrolyte complex as drug delivery carrier.Dr.S Ramakrishna, M.Pharm,Ph.D(External)Indian Institute of Chemical Technology.(IICT)Hyderabad.Mrs. K V Ratnamala, M.Pharm(Internal)<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"90%\">Preparation and characterization of mefenamic acid loaded polymeric nanoparticles by nano precipitation and desolvation technique.Dr.A Krishna Sailaja, M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"90%\">Formulation &amp; evaluation of or dispersible tablets of candasartan using natural super disintegrants.Mrs. G Uma Rani, M.PharmSupervisor<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td width=\"90%\">Formulation and evalution oof immediate release tablets of quinaprial Hcl by direct compression method.Dr.B L R Madhavi,M.Pharm,Ph.DSupervisor<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td width=\"90%\">Mr.Sridhar,M.Pharm(External)Pelcoat formulations pvt.ltd. survey no.13, kucharam village,toopran mandal,medak district.502336.Dr. A Krishna Sailaja ,M.Pharm,Ph.D(Internal) Pelcoat formulations pvt.ltd. survey no.13, kucharam village,toopran mandal, medak district. 502336.<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td width=\"90%\">Formulation and evaluation of non effervescent gastric floating tablets of ceferoxime axitel.Mrs. K V Ratnamala,M.Pharm.Supervisor<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2013<br \/>\nDepartment of Pharmaceutical Chemistry<\/strong><\/h1>\n<table class=\" alignleft\" width=\"100%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"92%\"><strong>Tittle of Project<br \/>\n<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"92%\">Synthesis , Charecterization , Docking studies and Biological evalution of 2,4,5,6 tetra substituted Pyridazin-3(2H)-ones<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"92%\">Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Sulfamoyl Phenyl Pyridazinones<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"92%\">Optimization , Charaterization &amp; impurity profile of Telmisartian by improved synthetic rout and evaluation of Antihypertensive activity of impurity (Chloro analaog)<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"92%\">Synthesis , Characterization and Docking studies of Novel series of Pyridazinone substituted Benzene Sulfonyl Ureas<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"92%\">Synthesis , Characterization , Docking and Biological Evalution of Novel Pyrimido(4,5-C) Pyridazines<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"92%\">Synthesis , Characterization , and In-Sillico evalution of Phthalazine derivatives as Antihypertensive agents<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"92%\">Synthesis , Characterization , Docking studies , and Biological evalution of Novel series of 4 Pyrazolyl Substituted Pyridazinones<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"92%\">Synthesis , Characterization , Docking studies, and Biological evalution of Novel series of Mannich bases of pyridazin 3(2H) thione<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2013<br \/>\nDepartment of Pharmaceutics<\/strong><\/h1>\n<table class=\" alignleft\" width=\"99%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"92%\"><strong>Tittle of Project<br \/>\n<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"92%\">Design , Development and Evaluation of Prednisolone Sodium Phosphate Orodispersible Tablets.<\/p>\n<p>Dr.B.L.R. Madhavi<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"92%\">Formulation and Evaluation of Sustained Release Matrix Tablets of Niacin<\/p>\n<p>Mrs. Ratnamala K V<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"92%\">Formulation , Characterization of imquimod w\/o\/w multiple emulsion for Novel Adjuvant delivery system<\/p>\n<p>Dr. H Sampath Kumar<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"92%\">Development and Evaluation of Compression coated timed release tablets of Candesartan Cilexetil for Chronotherapy<\/p>\n<p>Dr.B.L.R. Madhavi<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"92%\">Formulation and Evaluation of Compression coated immediate release tablets of Oseltamivir Phosphate<\/p>\n<p>Dr.B.L.R. Madhavi<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"92%\">Formulation and Evaluation of Quinapril Hydrochloride for oral sustained release<\/p>\n<p>Dr.B.L.R. Madhavi<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"92%\">Development of Nasal drug delivery system of Atorvastatin Calcium for enhancing bioavailability<\/p>\n<p>Mrs. G Uma Rani<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"92%\">Formulation and Evaluation of core coated colon specific tablets of Piroxicam<\/p>\n<p>Dr. A.K.Sailaja<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td width=\"92%\">A study of formulation of micro particle of Cefuroxime Axetil using Ethyl Cellulose<\/p>\n<p>Dr.B.L.R. Madhavi<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td width=\"92%\">Development and Evaluation of Naringenin loaded PLGA Nano particles for enhancement of oral Bioavailability<\/p>\n<p>Mr. S. Ramakrishna<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td width=\"92%\">Formulation and Evaluation of micro emulsions encompasing Muramyl dipeptide adjuvant as Novel Vaccine delivery system<\/p>\n<p>Dr. H.M. Sampath Kumar<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h1 style=\"text-align: center;\"><strong>2012<br \/>\nDepartment of\u00a0 Pharmaceutical Chemistry<\/strong><\/h1>\n<table class=\" alignleft\" width=\"99%\">\n<tbody>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td width=\"92%\"><strong>Tittle of Project<br \/>\n<\/strong><\/td>\n<\/tr>\n<tr>\n<td>1<\/td>\n<td width=\"92%\">Synthesis &amp; Docking studies of novel series of Pyridazine(6,1-c)(1,2,4) triazine derivatives as PDE4 inhibitors<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td width=\"92%\">Development of Industrial process for N-methyl pyridine-2-aldoxamine salts of Pharmaceutical importance.<\/p>\n<p>Prof.M.Sumakanth&amp;Dr.M.N.A.Rao<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td width=\"92%\">A novel synthesis , Characterization and Docking studies of 2-Thio-Substituted Benzo(d)thiazole derivatives<\/p>\n<p>Prof.M.Sumakanth&amp;Dr.Y.V.D.Nageswar<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td width=\"92%\">Synthesis characterization and docking studies of 2-substitutd 6-aryl pyridizin -3(2H)-ones as Dopaminengic agents<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td width=\"92%\">Synthesis characterization and docking studies of some novel series of 7-(o-Triazolopyridazin-3yl)-4-methyl coumarins as cox-2 inhibitors<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td width=\"92%\">Synthesis ,characterization ,&amp; docking studies of novel series of 2-[5(1H)tetrazolo]-yl-6-aryl-4,5-dihydro\/dehydro-pyridazin-3(2H)-one<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td width=\"92%\">Synthesis and docking studies of 3,7-disubstituted Pyridazin[6,1-C][1,2,4)-Triazines as novel PDE-4 inhibitors<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td width=\"92%\">Synthesis and molecular modeling of novel 2\u2013substituted -6-Aryl pyridazin-3(2H)ones as 5HT2A Antagonists<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td width=\"92%\">Synthesis , characterization and biological evaluation of Mannich bases of 7(hydroxyl)-4-methyl coumarin derivatives<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td width=\"92%\">Synthesis , Characterization and biological evaluation of novel 1,2,3 Tri-substituted Indoles<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>11<\/td>\n<td width=\"92%\">Synthesis , characterization and biological evaluation of a Schiff\u2019s bases of 2-(2-oxo-2-aryl)ethyl Pyridazin-3-thiones.<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>12<\/td>\n<td width=\"92%\">Synthesis , Docking studies and in vitro evaluation of Novel 4-(benzo[d] thiazol-2-yl)-N-phenylalanine derivatives<\/p>\n<p>Prof.M.Sumakanth&amp;Dr.Y.V.D.Nageswar<\/td>\n<\/tr>\n<tr>\n<td>13<\/td>\n<td width=\"92%\">Synthesis , characterization and Docking studies of Novel 6-Aryl \u2013 2-(Piperidin-1-yl\/Pyrrolidin-1-yl) Benzothiazole derivatives.<\/p>\n<p>Prof.M.Sumakanth&amp;Dr.Rajeev.S.Menon<\/td>\n<\/tr>\n<tr>\n<td>14<\/td>\n<td width=\"92%\">Molecular docking &amp; Virtual screening for Novel protein tyrosine Phosphatane 1B(PTPIB) inhebitors<\/p>\n<p>Dr.Pasupuleti Sreenivasa Rao<\/td>\n<\/tr>\n<tr>\n<td>15<\/td>\n<td width=\"92%\">Homology Modeling &amp; validation of Human FGFR 4 tyrosine kinase domine using structure based studies<\/p>\n<p>Prof.M.Sumakanth<\/td>\n<\/tr>\n<tr>\n<td>16<\/td>\n<td width=\"92%\">In-Silico of Inhibitors for the Human SIAH2, implications for Hypoxia- induced cancers.<\/p>\n<p>Dr.Pasupuleti Sreenivasa Rao<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: left;\">\n","protected":false},"excerpt":{"rendered":"<p>2017 Department of Pharma.Analysis \u00a0Sl.no \u00a0Title of the Project 1. Method development and validation of Moxifloxacin using RP-HPLC and UV-Method A.Chaitanya Dr. M.Sumakanth M.Pharm Ph.D 2. Method development and validation of ATOMOXETINE by RP-HPLC&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/child-menu.php","meta":{"footnotes":""},"class_list":["post-211","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/pages\/211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/comments?post=211"}],"version-history":[{"count":5,"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/pages\/211\/revisions"}],"predecessor-version":[{"id":2524,"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/pages\/211\/revisions\/2524"}],"up":[{"embeddable":true,"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/pages\/7"}],"wp:attachment":[{"href":"https:\/\/www.rbvrrwcp.org\/oldsite\/wp-json\/wp\/v2\/media?parent=211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}